SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $316,538,000 | -11.3% | 3,245,542 | -15.6% | 1.72% | -2.7% |
| Q4 2014 | $356,972,000 | +32.2% | 3,847,094 | -2.0% | 1.77% | +42.2% |
| Q3 2014 | $270,099,000 | -26.8% | 3,927,006 | +11.5% | 1.24% | -16.1% |
| Q2 2014 | $369,001,000 | +43.8% | 3,521,000 | +13.8% | 1.48% | +46.8% |
| Q1 2014 | $256,626,000 | +23.3% | 3,093,000 | -3.9% | 1.01% | +26.9% |
| Q4 2013 | $208,204,000 | +2.0% | 3,217,000 | -0.2% | 0.80% | -3.3% |
| Q3 2013 | $204,111,000 | +95.5% | 3,224,000 | +29.7% | 0.82% | +79.9% |
| Q2 2013 | $104,382,000 | – | 2,485,288 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |